BCRX - BioCryst Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts9999
Avg. Estimate-0.31-0.31-1.22-1.08
Low Estimate-0.34-0.35-1.28-1.42
High Estimate-0.25-0.28-1.14-0.69
Year Ago EPS-0.19-0.28-0.98-1.22
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts8899
Avg. Estimate2.02M3.74M15.44M37.62M
Low EstimateN/A900k8.7M9.33M
High Estimate7M7M27M89M
Year Ago Sales12.49M1.45M20.65M15.44M
Sales Growth (year/est)-83.80%157.20%-25.20%143.70%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.24-0.26-0.25-0.27
EPS Actual-0.19-0.28-0.25-0.28
Difference0.05-0.020-0.01
Surprise %20.80%-7.70%0.00%-3.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.31-0.31-1.22-1.08
7 Days Ago-0.31-0.31-1.22-1.08
30 Days Ago-0.31-0.31-1.22-1.08
60 Days Ago-0.31-0.31-1.22-1.11
90 Days Ago-0.29-0.29-1.18-1.18
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBCRXIndustrySectorS&P 500
Current Qtr.-63.20%N/AN/A0.01
Next Qtr.-10.70%N/AN/A0.03
Current Year-24.50%N/AN/A0.04
Next Year11.50%N/AN/A0.10
Next 5 Years (per annum)19.90%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A